The contribution of pharmacoepidemiology to the antidepressant-suicidality debate in children and adolescents

References

• Brent DA. Antidepressants and pediatric depression–the risk of doing nothing. New England Journal of Medicine 2004; 351(16)1598–1601
   PubMed Web of Science ®Google Scholar
• Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. Journal of the American Medical Association 2007; 297: 1683–1696
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. 2007, Mortality Query, CDC Wonder, Data and Statistics (http:/wonder.cdc.gov/mortSQL.html; accessed 7/15/2007)
   Google Scholar
• Couzin J. Psychopharmacology. Study questions antidepressant risks. Science 2007; 316(5823)354
   PubMedGoogle Scholar
• Gibbons RD, Hur K, Bhaumik DK, Mann JJ. The relationship between antidepressant prescription rates and rate of early adolescent suicide. American Journal of Psychiatry 2006; 163(11)1898–1904
   PubMedGoogle Scholar
• Hamilton BE, Minino AM, Martin JA, Kochanek KD, Strobino DM, Guyer B. Annual summary of vital statistics: 2005. Pediatrics 2007; 119(2)345–360
   PubMedGoogle Scholar
• Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry 2006; 63: 332–339
   PubMed Web of Science ®Google Scholar
• Hunter D. First, gather the data. New England Journal of Medicine 2006; 354: 329–331
   PubMedGoogle Scholar
• Isacsson G, Holmgren P, Ahlner J. Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: A controlled forensic database study of 14,857 suicides. Acta Psychiatrica Scandinavica 2005; 111: 286–290
   PubMed Web of Science ®Google Scholar
• Isacsson G, Rich CL. Antidepressant drug use and suicide prevention. International Review of Psychiatry 2005; 17(3)153–162
   PubMed Web of Science ®Google Scholar
• Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. Journal of the American Medical Association 2004; 292: 338–343
   PubMed Web of Science ®Google Scholar
• Kurdyak PA, Juurlink DN, Mamdani MM. The effect of antidepressant warnings on prescribing trends in Ontario, Canada. American Journal of Public Health 2007; 97: 750–754
   PubMedGoogle Scholar
• Kurian BT, Ray WA, Arbogast PG, Fuchs DC, Dudley JA, Cooper WO. Effect of regulatory warnings on antidepressant prescribing for children and adolescents. Archives of Pediatrics and Adolescent Medicine 2007; 161(7)690–696
   PubMed Web of Science ®Google Scholar
• Leon AC, Marzuk PM, Tardiff K, Bucciarelli A, Markham Piper T, Galea S. Antidepressants and youth suicide in New York City, 1999–2002. Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45(9)1054–1058
   PubMedGoogle Scholar
• Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. American Journal of Psychiatry 2007; 164(6)884–891
   PubMed Web of Science ®Google Scholar
• Lubell KM, Kegler SR, Crosby AE, Karch D. Suicide trends among youths and young adults aged 10–24 years-United States, 1990–2004. Morbidity and Mortality Weekly Report 2007; 56: 905–908
   PubMedGoogle Scholar
• Martinez C, Rietbrock S, Wise L, Ashby D, Chick J, Moseley J, et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: Nested case-control study. British Medical Journal 2005; 330(7488)389
   PubMedGoogle Scholar
• Murray ML, Thompson M, Santosh PJ, Wong IC. Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK. Drug Safety: An International Journal of Medical Toxicology and Drug Experience 2005; 28(12)1151–1157
   PubMedGoogle Scholar
• Nemeroff CB, Kalali A, Keller MB, Charney DS, Lenderts SE, Cascade EF, et al. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Archives of General Psychiatry 2007; 64: 466–472
   PubMed Web of Science ®Google Scholar
• Olfson M, Marcus SC, Shaffer D. Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study. Archives of General Psychiatry 2006; 63: 865–872
   PubMed Web of Science ®Google Scholar
• Olfson M, Shaffer D, Marcus SC, Greenberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Archives of General Psychiatry 2003; 60(10)978–982
   PubMed Web of Science ®Google Scholar
• Simon GE, Savarino J. Suicide attempts among patients starting depression treatment with medications or psychotherapy. American Journal of Psychiatry 2007; 164(7)1029–1034
   PubMed Web of Science ®Google Scholar
• Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. American Journal of Psychiatry 2006; 163(1)41–47
   PubMed Web of Science ®Google Scholar
• Sondergard L, Kvist K, Andersen PK, Kessing LV. Do antidepressants precipitate youth suicide? A nationwide pharmacoepidemiological study. European Child and Adolescent Psychiatry 2006; 15(4)232–240
   PubMedGoogle Scholar
• Strom BL. What is pharmacoepidemiology?. Textbook of Pharmacoepidemiology(Fourth edition, BL Strom, SE Kimmel. John Wiley & Sons, Ltd, Chichester 2006; 3–11
   Google Scholar
• Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Tanskanen A, Haukka J. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Archives of General Psychiatry 2006; 63(12)1358–1367
   PubMed Web of Science ®Google Scholar
• Food US and Drug Administration. Class suicidality labeling language for antidepressants 2004, http://www.fda.gov/cder/drug/antidepressants/PI_template.pdf (accessed 7/01/05)
   Google Scholar
• Food US and Drug Administration. Clinical review: Relationship between antidepressant drugs and suicidality in adults 2006, http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-01-FDA.pdf (accessed 8/13/07)
   Google Scholar
• Food US and Drug Administration. FDA proposes new warnings about suicidal thinking, behavior in young adults who take antidepressant medications 2007, http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html (accessed 8/22/07)
   Google Scholar
• Valuck RJ, Libby AM, Orton HD, Morrato EH, Allen R, Baldessarini RJ. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. American Journal of Psychiatry 2007; 164(8)1198–1205
   PubMedGoogle Scholar
• Valuck RJ, Libby AM, Sills MR, Giese AA, Allen RR. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: A propensity-adjusted retrospective cohort study. CNS Drugs 2004; 18(15)1119–1132
   PubMedGoogle Scholar
• Vitiello B, Riddle MA, Greenhill LL, March JS, Levine J, Schachar RJ, et al. How can we improve the assessment of safety in child and adolescent psychopharmacology?. Journal of the American Academy of Child & Adolescent Psychiatry 2003; 42(6)634–641
   PubMedGoogle Scholar
• Vitiello B, Zuvekas SH, Norquist GS. National estimates of antidepressant medication use among US children, 1997–2002. Journal of the American Academy of Child Adolescent Psychiatry 2006; 45(3)271–279
   PubMedGoogle Scholar
• Zito JM, Safer DJ, DosReis S, Gardner JF, Soeken K, Boles M, et al. Rising prevalence of antidepressants among US youths. Pediatrics 2002; 109(5)721–727
   PubMed Web of Science ®Google Scholar